Effects of low-intensity ultrasound opening the blood-brain barrier on Alzheimer's disease—a mini review

Effects of low-intensity ultrasound opening the blood-brain barrier on Alzheimer's disease—a mini review

Due to the complex pathological mechanisms of Alzheimer's disease (AD), its treatment remains a challenge. One of the major difficulties in treating AD is the difficulty for drugs to cross the blood–brain barrier (BBB). Low-intensity ultrasound (LIUS) is a novel type of ultrasound with neuromod...

Detaylı Bibliyografya
Asıl Yazarlar:	Mengmeng Zhou, Xuanhao Fu, Boyuan Ma, Ziyu Chen, Yuelin Cheng, Linyan Liu, Shunli Kan, Xinyan Zhao, Sa Feng, Zehua Jiang, Rusen Zhu
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2023-11-01
Seri Bilgileri:	Frontiers in Neurology
Konular:	low-intensity ultrasound blood-brain barrier opening Alzheimer's disease β-amyloid tau
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1274642/full

Benzer Materyaller

Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
Yazar:: Iram Iqbal, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
Yazar:: So Hee Park, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
Yazar:: Kaden L. Nystuen, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Early diagnosis and treatment of Alzheimer’s disease: new definitions and challenges
Yazar:: Marcos Pais, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

GSK3 and Alzheimer's disease: facts & fiction …
Yazar:: Fred eVanleuven
Baskı/Yayın Bilgisi: (2011-08-01)

The presubiculum is preserved from neurodegenerative changes in Alzheimer’s disease
Yazar:: Christina E. Murray, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
Yazar:: Brendan P. Lucey
Baskı/Yayın Bilgisi: (2020-10-01)

β-Amyloid Plaque Reduction in the Hippocampus After Focused Ultrasound-Induced Blood–Brain Barrier Opening in Alzheimer’s Disease
Yazar:: Pierre-François D’Haese, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
Yazar:: Md. Sahab Uddin, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

Pathological correlates of impaired self-awareness of memory function in Alzheimer’s disease
Yazar:: Geoffroy Gagliardi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease
Yazar:: Junjian Zeng, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Alzheimer’s disease and anesthesia
Yazar:: Marie-Amélie ePapon, ve diğerleri
Baskı/Yayın Bilgisi: (2011-01-01)

Protein phosphatase 2A dysfunction in Alzheimer’s disease
Yazar:: Jean-Marie eSontag, ve diğerleri
Baskı/Yayın Bilgisi: (2014-03-01)

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease
Yazar:: Cassia R. Overk, ve diğerleri
Baskı/Yayın Bilgisi: (2009-09-01)

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
Yazar:: Yuanxin Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Evaluating Circadian Dysfunction in Mouse Models of Alzheimer’s Disease: Where Do We Stand?
Yazar:: Patrick W. Sheehan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target?
Yazar:: Castillo-Carranza DL, ve diğerleri
Baskı/Yayın Bilgisi: (2013-12-01)

Role of liraglutide in Alzheimer’s disease pathology
Yazar:: Maria Vargas-Soria, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Focused ultrasound therapy for Alzheimer’s disease: exploring the potential for targeted amyloid disaggregation
Yazar:: Kurt Scott, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
Yazar:: Yvonne S. Davidson, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
Yazar:: Stephanie R. Oatman, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
Yazar:: Daniel Lamontagne-Kam, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Imaging Aβ and tau in early stage Alzheimer’s disease with [18F]AV45 and [18F]AV1451
Yazar:: Azadeh Firouzian, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease
Yazar:: Juanjuan Zhao, ve diğerleri
Baskı/Yayın Bilgisi: (2017-07-01)

Synaptic activity and Alzheimer’s disease: a critical update
Yazar:: Davide eTampellini
Baskı/Yayın Bilgisi: (2015-11-01)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
Yazar:: Yuehua Huang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
Yazar:: Guimei Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease
Yazar:: Linda J. Van Eldik, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
Yazar:: Mahmoud B. Maina, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

The emerging double-edged sword role of exosomes in Alzheimer’s disease
Yazar:: Tao Liang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Sex Differences in Autophagy Contribute to Female Vulnerability in Alzheimer's Disease
Yazar:: Erin E. Congdon
Baskı/Yayın Bilgisi: (2018-06-01)

Time between milestone events in the Alzheimer's disease amyloid cascade
Yazar:: Philip S. Insel, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Is later-life depression a risk factor for Alzheimer’s disease or a prodromal symptom: a study using post-mortem human brain tissue?
Yazar:: Lindsey I. Sinclair, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
Yazar:: Donovan A. McGrowder, ve diğerleri
Baskı/Yayın Bilgisi: (2021-02-01)

Mechanisms of Pathogenic Tau and Aβ Protein Spreading in Alzheimer’s Disease
Yazar:: Paolo d‘Errico, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Expanding the repertoire of biomarkers for Alzheimer’s disease: targeted and non-targeted approaches.
Yazar:: Douglas eGalasko
Baskı/Yayın Bilgisi: (2015-12-01)

Diagnostic performance of plasma pTau217, pTau181, Aβ1-42 and Aβ1-40 in the LUMIPULSE automated platform for the detection of Alzheimer disease
Yazar:: Javier Arranz, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
Yazar:: Josef Marksteiner, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Physiopathological mechanisms underlying Alzheimer’s disease: a narrative review
Yazar:: Eliasz Engelhardt, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Mouse Models of Alzheimer’s Disease
Yazar:: Miyabishara Yokoyama, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)